All In MedTech

Device Trial Radar · NCT05467345

Evaluation of the Performance of CONTOUR NEXT® and CONTOUR PLUS ELITE® BGMS in Neonates Using Capillary Blood Samples

Evaluation of the Performance of CONTOUR NEXT® and CONTOUR PLUS ELITE® Blood Glucose Monitoring Systems (BGMS) in Neonates Using Capillary Blood Samples

Last checked: Nov 21, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

120

Actual

Start

Aug 24, 2022

Primary completion

Nov 30, 2022

Study completion Mar 14, 2023

Sponsor

Lead sponsor
Ascensia Diabetes CareNot on our public-company list
Sponsor type
Industry
First posted
Jul 20, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 0 days, up to 27 days
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to extend the intended use of two BGMSs to include testing of neonatal blood by Health Care Professionals in a clinical setting for the quantitative measurement of glucose levels in neonates.

Conditions

  • Diabetes Mellitus

Interventions

  • Contour Next and Contour Plus Elite BGMS testing of neonatal bloodDevice

    The purpose of this study is to extend the intended use of two BGMSs to include testing of neonatal blood by Health Care Professionals in a clinical setting for the quantitative measurement of glucose levels in neonates.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Results From the Contour Next BGMSs Reference Values Within ±12.5% of Reference ValuesTime frame: 1 day

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • St. Louis Children's Hospital, Washington University

    St Louis, Missouri

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.